|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
102,087,000 |
Market
Cap: |
N/A |
Last
Volume: |
3,941,702 |
Avg
Vol: |
1,796,900 |
52
Week Range: |
$45.85 - $45.85 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Jackson Hunter |
President, CEO and Chairman |
|
2004-02-02 |
4 |
AS |
$34.28 |
$142,823 |
I/I |
(4,166) |
24,170 |
|
- |
|
Jackson Hunter |
President, CEO and Chairman |
|
2004-02-02 |
4 |
AS |
$34.24 |
$57,051 |
D/D |
(1,666) |
22,482 |
|
- |
|
Parks Thomas N |
Director |
|
2004-02-02 |
4 |
AS |
$34.29 |
$129,490 |
I/I |
(3,776) |
18,008 |
|
- |
|
Parks Thomas N |
Director |
|
2004-02-02 |
4 |
AS |
$34.40 |
$17,200 |
D/D |
(500) |
208,405 |
|
- |
|
Marriott Thomas B III |
VP, Development Research |
|
2004-02-02 |
4 |
S |
$33.91 |
$101,727 |
D/D |
(3,000) |
20,339 |
|
- |
|
Marriott Thomas B III |
VP, Development Research |
|
2004-02-02 |
4 |
OE |
$8.25 |
$24,750 |
D/D |
3,000 |
23,339 |
|
- |
|
Nemeth Edward F |
VP & Chief Scientific Officer |
|
2004-01-20 |
4 |
AS |
$34.87 |
$174,368 |
D/D |
(5,000) |
91,876 |
|
- |
|
Jackson Hunter |
President, CEO and Chairman |
|
2004-01-20 |
4 |
AS |
$34.91 |
$145,433 |
I/I |
(4,166) |
26,253 |
|
- |
|
Jackson Hunter |
President, CEO and Chairman |
|
2004-01-20 |
4 |
AS |
$34.91 |
$58,163 |
D/D |
(1,666) |
24,148 |
|
- |
|
Parks Thomas N |
Director |
|
2004-01-20 |
4 |
AS |
$34.91 |
$317,045 |
I/I |
(9,076) |
19,896 |
|
- |
|
Parks Thomas N |
Director |
|
2004-01-20 |
4 |
AS |
$34.97 |
$26,225 |
D/D |
(750) |
208,905 |
|
- |
|
Mueller Alan L |
VP, Drug Discovery |
|
2004-01-15 |
4 |
AS |
$34.39 |
$51,590 |
I/I |
(1,500) |
23,970 |
|
- |
|
Evans John Robert |
Director |
|
2004-01-13 |
4 |
OE |
$14.64 |
$4,743 |
D/D |
324 |
79,423 |
|
- |
|
Marriott Thomas B III |
VP, Development Research |
|
2004-01-13 |
4 |
OE |
$3.00 |
$20,520 |
D/D |
6,840 |
20,339 |
|
- |
|
Marriott Thomas B III |
VP, Development Research |
|
2004-01-13 |
4 |
D |
$34.50 |
$20,493 |
D/D |
(594) |
13,499 |
|
- |
|
Parrish Stephen R |
VP, Manufacturing |
|
2004-01-09 |
4 |
AS |
$34.95 |
$27,960 |
D/D |
(800) |
0 |
|
- |
|
Parrish Stephen R |
VP, Manufacturing |
|
2004-01-09 |
4 |
OE |
$17.83 |
$14,264 |
D/D |
800 |
800 |
|
- |
|
Parks Thomas N |
Director |
|
2004-01-09 |
4 |
AS |
$35.00 |
$175,000 |
I/I |
(5,000) |
24,284 |
|
- |
|
Parks Thomas N |
Director |
|
2004-01-09 |
4 |
AS |
$35.00 |
$8,750 |
D/D |
(250) |
209,655 |
|
- |
|
Marriott Thomas B III |
VP, Development Research |
|
2004-01-09 |
4 |
AS |
$35.00 |
$350,000 |
D/D |
(10,000) |
14,093 |
|
- |
|
Marriott Thomas B III |
VP, Development Research |
|
2004-01-09 |
4 |
OE |
$4.50 |
$54,254 |
D/D |
10,000 |
24,093 |
|
- |
|
Stiller Calvin |
Director |
|
2004-01-06 |
4 |
A |
$31.60 |
$85,320 |
D/D |
2,700 |
7,900 |
|
- |
|
Evans John Robert |
Director |
|
2004-01-06 |
4 |
A |
$31.60 |
$88,480 |
D/D |
2,800 |
79,099 |
|
- |
|
Klein Joseph III |
Director |
|
2004-01-06 |
4 |
A |
$31.60 |
$97,960 |
D/D |
3,100 |
3,100 |
|
- |
|
Kuhla Donald E |
Director |
|
2004-01-06 |
4 |
A |
$31.60 |
$66,360 |
D/D |
2,100 |
35,600 |
|
- |
|
574 Records found
|
|
Page 17 of 23 |
|
|